Cross-talk between signaling pathways plays an important role in regulation of cell growth, differentiation, survival, and death. Here, we show that Akt regulates the Elk-1 transcription factor, independent of its negative regulation of Raf kinases. Using a constitutively active Mek1 to bypass the regulation of Raf by Akt, we find that the Elk-1 and Sap1a proteins are dramatically decreased in the presence of activated Akt. Akt catalytic activity is required. Also, Mek-dependent activation of a TCF (Elk-1/Sap-1a)-dependent c-fos reporter is decreased by activated Akt. Neither the level of Elk-1 mRNA nor the stability of the Elk-1 protein is altered by activated Akt. Instead, the rate of incorporation of labeled methionine into Elk-1 protein is decreased in the presence of Akt. In addition, the level of the Elk-1 protein but not GFP is significantly decreased in the presence of activated Akt, when GFP is expressed from an IRES element in a bicistronic message with Elk-1. We conclude that Akt negatively regulates translation of the Elk-1 mRNA. A coding region determinant that maps within the first 279 nts of the Elk-1 message is necessary and sufficient for Akt-mediated regulation of Elk-1.
Introduction
Ras is activated in response to numerous environmental cues, including growth factors, cytokines, and hormones. Active, GTP-bound Ras recruits Raf to the plasma membrane, where phosphorylation of serine/threonine and tyrosine residues and interaction with phospholipids and 14-3-3 proteins leads to full activation of Raf enzymatic activity (Morrison and Cutler, 1997) . Activated Raf phosphorylates Mek, which in turn phosphorylates and activates the mitogen-activated protein kinase (MAPK), extracellular regulated kinase (Erk) 1/2. Erk dimerizes and translocates to the nucleus where it stimulates the activity of transcription factors, including Elk-1 (Pearson et al., 2001) .
Elk-1, together with Sap1a and Sap2/Erp/Net define the ternary complex factor (TCF) subfamily of Ets domain transcription factors. These proteins form ternary complexes with serum response factor (SRF) and serum response elements (SRE) found in immediate early genes such as c-fos. Each TCF protein contains four conserved domains: the Ets DNA-binding domain or A-box; the SRF interaction domain or B-box; the activation domain or C-box; and the MAPK-docking domain or D-box . TCFs are phosphorylated by MAPKs at multiple sites within the activation domain. Erk phosphorylates and activates Elk-1 and Sap1a (Sharrocks et al., 2000) . Phosphorylation of Elk-1 by Erk is important for its binding and/or functional cooperation with coactivators such as Sur2 and CBP (Janknecht and Nordheim, 1996; Stevens et al., 2002) .
In addition to activation of the Raf/Mek/Erk kinase cascade, Ras activates phosphatidylinositol 3-kinase (PI3K) and the serine/threonine kinase Akt (Vojtek and Der, 1998; Ayllon and Rebollo, 2000) . Akt regulates a variety of biological effects, including cell size, glycogen metabolism, cell-cycle regulation, cell proliferation and cell survival (Datta et al., 1999) .
Cross-talk between the PI3K/Akt and Raf/Mek/Erk pathways is important in the regulation of cell growth, differentiation, survival and death, and in determining which biological outcome will predominate. One molecular mechanism for cross-talk between these two pathways is negative regulation of Raf kinases by Akt. We and others have previously demonstrated that Akt phosphorylates Raf and phosphorylation downregulates the enzymatic activity of c-Raf and B-Raf (Jun et al., 1999; Zimmermann and Moelling, 1999; Guan et al., 2000) . In this study, we show that Akt negatively regulates the Raf/Mek/Erk pathway at a second point by regulating the Elk-1 transcription factor. Using a constitutively active (C/A) Mek1 to bypass the regulation by Akt of the Raf kinases, we demonstrate that Elk-1 protein levels are dramatically decreased by activated Akt. C/A Mek1-induced transcriptional activation of the TCF-regulated c-fos reporter gene is also inhibited in the presence of activated Akt. A coding region determinant (nts 1-279) is necessary and sufficient for the Akt-promoted decrease in Elk-1. The level of the Sap1a protein, a second member of the TCF subfamily of Ets domain transcription factors, is also decreased in the presence of activated Akt. Activated Akt does not alter the level of Elk-1 mRNA or the stability of the Elk-1 protein. However, in the presence of activated Akt, the rate of incorporation of labeled methionine into Elk-1 protein is decreased. In addition, Elk-1 but not green fluorescent protein (GFP) levels are significantly decreased in the presence of activated Akt, when GFP is expressed from an internal ribosome entry site (IRES) element in a bicistronic message with Elk-1. Taken together, these results suggest that Akt negatively regulates translation of the Elk-1 mRNA through a coding region determinant located within the Ets domain.
Results

Elk-1 protein levels are decreased by activated Akt
We and others have previously demonstrated that Akt negatively regulates Raf catalytic activity Guan et al., 2000) . To determine if Akt acts at additional steps within the Raf/Mek/Erk cascade, HEK 293 cells were transiently transfected with expression vectors for glutathione-S-transferase epitopetagged Elk-1 (GST-Elk-1), Myc epitope-tagged cyclase associated protein (MT-CAP, internal control), C/A Mek1, and C/A myristylated (myr)-Akt. C/A Mek1 is used to activate the signaling pathway and to bypass the block on the Raf proteins imposed by activated Akt. To confirm that C/A Mek1 bypassed the negative regulation of Raf kinases by Akt, Erk catalytic activity, as determined by in vitro kinase reactions and Erk-directed phosphorylation of Elk-1 S383 in vivo, was assayed and found to be unaffected by activated Akt (data not shown).
In the presence of C/A Akt and Mek1, we observed a dramatic decrease in the level of the GST-Elk-1 protein ( Figure 1a ). Activated Akt reduced the steady-state level of GST-Elk-1 by approximately fivefold (lane 1 vs lane 3, Figure 1a) . A similar result was observed after Western blot analysis of Elk-1 protein obtained from whole cell extracts, indicating that differential extraction was unlikely to account for the difference in Elk-1 protein levels with and without expression of activated Akt (data not shown). We obtained similar results with Elk-1 fused at its amino terminus with different tags (HA and the Gal4 DNA-binding domain) and with untagged Elk-1 (Figure 1b) . It is unlikely that this effect is due to inhibition of the simian CMV promoter of the Elk-1 expression vector by Akt because the internal control, MT-CAP, is expressed in the same expression vector as Elk-1 and is not significantly affected by activated Akt. In addition, similar results were obtained with two different activated versions of Akt: myristylated, membrane localized Akt and DPHDDAKT (data not shown). DPHDDAkt lacks the PH domain and activating phosphorylation residues, Thr308 and Ser473, are substituted with aspartic acids to simulate the phosphorylated and active state of Akt. Finally, this regulation of Elk-1 protein by Akt is not cell type specific since we obtain similar results in Cos-1 cells and P19 cells (data not shown). These data suggest that activated Akt regulates the Raf/Mek/ Erk pathway at a second point downstream of Mek and that this regulation of the pathway by Akt results in a decrease in Elk-1 protein levels.
In order to address the requirement for Akt kinase activity, cells transfected with GST-Elk-1, MT-CAP and C/A Mek1 were treated with the PI3K/Akt inhibitor LY294002 prior to cell harvest. As expected, LY294002 inhibited the activation of endogenous Akt, as assessed by Western analysis with phospho-Akt (S473) antibody (Figure 1c) . GST-Elk-1 levels were increased by the addition of LY, indicating that activation of the endogenous PI3K/Akt signaling pathway negatively regulates Elk-1 levels. Vanhoutte et al. (2001) reported the presence of an Elk-1 isoform, short (s) Elk-1, in brain and in NGF-differentiated PC12 cells. sElk-1 is expressed from an internal translation start site and the protein lacks the first 54 aa of Elk-1. The decrease that we observe in Elk-1 protein levels in the presence of Akt is not simply due to a shift from Elk-1 to sElk-1. Western blot analysis with an Elk-1-specific antibody that recognizes an epitope within the carboxyl terminal domain of both proteins does not detect the short version of Elk-1 in the presence of Akt (Figure 1b , data not shown). 
Expression of constitutively active Akt decreases the transcriptional activity of a c-fos reporter gene
To examine the impact of activated Akt on endogenous TCFs, we measured the activity of a c-fos reporter gene. The c-fos promoter in this reporter is regulated by endogenous TCFs, including Elk-1. Actively growing Cos cells were transfected with a c-fos luciferase reporter, b-galactosidase, C/A Mek1, and either constitutively active Akt (Myr-Akt) or kinase inactive Akt (Myr-Akt K/D). The basal activity of the c-fos reporter was enhanced approximately ninefold by C/A Mek1. Activated Akt, but not kinase inactive Akt, decreased Mek1-induced transcription of the c-fos reporter gene ( Figure 2 ). Thus, Akt negatively regulates the c-fos promoter and Akt kinase activity is required. Since activated Akt reduces the steady-state level of Elk-1 protein, it seems likely that Akt negatively regulates the c-fos promoter by regulating the levels of endogenous TCFs; however, Akt may also regulate the c-fos promoter by additional mechanisms.
Akt regulates Elk-1 by a post-transcriptional mechanism
A decrease in Elk-1 protein levels could be due to the decreased rate of synthesis of Elk-1 protein or the increased rate of degradation of Elk-1 protein in the presence of activated Akt. A decrease in the rate of synthesis of Elk-1 protein could be caused by decreased synthesis or increased degradation of Elk-1 mRNA or decreased rate of translation of Elk-1 mRNA. To investigate whether Akt was affecting the stability of the Elk-1 protein, we performed pulse-chase experiments in 293 cells transfected with expression vectors for GST-Elk-1, C/A Mek1, and MT-CAP (internal control). The cells were pulsed for 1 h with [ 35 S]methionine and then chased with cold methionine. GST-Elk-1 was purified from cells using glutathione sepharose and the incorporation of label into Elk-1 determined by phosphorimage analysis following SDS-PAGE. The half-life of Elk-1 was the same with and without myr-Akt, approximately 3.5 h (Figure 3 ). In addition, proteasome inhibitors did not stabilize Elk-1 in the presence of activated Akt (data not shown). Taken ]methionine into the internal control, MT-CAP, was not affected by myr-Akt (data not shown). This decrease in incorporation of label into GST-Elk could be due to decreased synthesis or increased degradation of Elk-1 mRNA or translational regulation.
To determine whether expression of activated Akt decreased the steady-state level of the Elk-1 message, Northern blot analysis was performed (Figure 4 ). The steady-state levels of messages that encode the Gal4 DNA-binding domain (GAL) fused to full-length Elk-1 or domains of Elk-1 were not decreased in RNA samples harvested from cells with activated Akt. Rather, there was a modest increase (less than 1.5-2 Â ) in Elk mRNA levels harvested from cells with activated Akt.
To assess whether translation of the Elk-1 message was decreased in the presence of activated Akt, cells with and without activated Akt were pulsed with [ GST-Elk-1 was purified from lysates from cells transfected as in Figure 1 , pulsed with labeled methionine, and chased for the times indicated. The samples were analysed by SDS-PAGE followed by phosphorimage analysis (a) and Western blot analysis with a-Elk-1 antibodies (not shown). [35-S]methionine incorporation at each time point was determined from the phosphorimage; protein levels were determined by quantitating the a-Elk-1 Western blot with NIH Image. Time ¼ 0 was set to 100% and best-fit lines were calculated (b)
Negative regulation of Elk-1 translation by Akt C Figueroa and AB Vojtek assessed by phosphorimage analysis after SDS-PAGE. The rate of incorporation of label into Elk-1 in the presence of activated Akt was reduced approximately fourfold ( Figure 5 ). Neither the level of protein nor the rate of incorporation of label into the internal control, MT-CAP, were significantly affected by Akt (data not shown). These results suggest that the rate of translation of the Elk-1 mRNA is regulated by activated Akt. In order to provide additional evidence for translational control, we assessed the effect of activated Akt on the translation of a bicistronic mRNA, in which the coding region for the GAL-Elk fusion protein is followed by an IRES element that directs the expression of GFP. HEK 293 cells were transfected with this expression vector together with expression vectors for C/A Mek1, MT-CAP, luciferase, and increasing concentrations of myr-Akt. Cell extracts were normalized with respect to luciferase and proteins were resolved by SDS-PAGE and analysed by Western blotting. GALElk-1 protein levels decreased in a dose-dependent manner in the presence of myr-Akt; however, the level of the GFP protein, expressed from the IRES element, did not change with increasing Akt concentrations ( Figure 6 ). MT-CAP is a second internal control and its levels do not vary with increasing Akt concentrations. This result provides additional support for Akt as a negative regulator of translation of the Elk-1 message.
An Elk-1 coding region determinant is required for negative regulation of Elk-1 translation by Akt
To map the region in Elk-1 that negatively regulates translation in the presence of activated Akt, chimeric GAL-Elk fusion proteins were expressed in vivo and the level of the GAL-Elk-1 fusion proteins was assessed by Western blot analysis. The levels of GAL-ElkFL (full length, aa 1-428, nts 1-1284), GAL-ElkEts þ B Figure 4 Steady-state levels of Elk-1 mRNA are not decreased by activated Akt. HEK 293 cells were transiently transfected with GAL-Elk-1 constructs (see Figure 7) , C/A Mek1 and myr-Akt. Total RNA was isolated from cells 18 h after transfection and subjected to Northern blot analysis using radiolabeled probes against the GAL4 DNA-binding domain (GAL) and GAPDH (internal control) (aa 1-206, nts 1-618), and GAL-ElkNT (aa 1-93, nts 1-279) were decreased in extracts prepared from cells expressing activated Akt (Figure 7) . The level of GALElkCT (aa 205-428, nts 615-1284) was equivalent in extracts prepared from cells with and without activated Akt. Thus, nts 1-279 of Elk-1 contain a coding region determinant that is necessary and sufficient for negative regulation of Elk-1 translation by activated Akt.
Negative regulation of Sap1a by Akt
Elk-1 and Sap1a are members of the TCF subfamily of Ets-containing proteins. Within the first 279 nts, which in Elk-1 contains the coding region determinant mediating translational control, Elk-1 and Sap1a are 72% identical at the nucleotide level. Given this high degree of homology at the nucleotide level, we investigated whether myr-Akt alters Sap1a protein levels, as observed for Elk-1. The level of the Sap1a protein was assessed by Western blot analysis of cell lysates from HEK 293 cells transiently expressing a GST-Sap1a fusion protein, C/A Mek1, MT-CAP, and increasing concentrations of Akt. GST-Sap1a protein levels were reduced by myr-Akt in a dose-dependent manner (Figure 8 ). We think that it is likely that this decrease in Sap1a protein levels reflects regulation of Sap1a by Akt at the level of mRNA translation, as we have observed for Elk-1.
Elk-1 protein levels are not reduced by activated SGK
Serum and glucocorticoid-inducible serine/threonine kinase (SGK) exhibits high sequence similarity with Akt and both share a related phosphorylation consensus site (RXRXXS/T) (Brunet et al., 2001) . To investigate whether Elk-1 protein levels were decreased in the presence of activated SGK, we cotransfected HEK 293 cells with expression vectors for C/A Mek1, GST-Elk-1, MT-CAP, and increasing concentrations of HA-tagged C/A SGK. Elk-1 protein levels were essentially the same with and without activated SGK (Figure 9 ). Thus, regulation of Elk-1 protein levels is likely to be the result of the action of Akt on a substrate(s) not shared in common with SGK.
Discussion
Cross-talk between the PI3K/Akt and Raf/Mek/Erk pathways plays a critical role in regulating cell growth, differentiation, and survival. Zimmermann and Moelling (1999) demonstrated that constitutively active Akt inhibits c-Raf catalytic activity and Raf/Mek/ Erk induced elevation of p21CIP1 in PMA-stimulated MCF7 cells, suggesting that negative regulation of the Raf/Mek/Erk pathway by activated Akt plays a role in determining whether cells proliferate or growth arrest. Rommel et al. (1999 Rommel et al. ( , 2001 showed that the Raf/Mek/Erk pathway and Akt have opposing effects on muscle cell hypertrophy. We have demonstrated that epidermal growth factor stimulation of B-Raf activity is inhibited by coexpression of activated Akt (Guan et al., 2000) . On the other hand, numerous studies have demonstrated cooperativity between Raf/Mek/Erk and PI3K/Akt in cell cycle progression, proliferation, and transformation (Choudhury et al., 1997; Choudhury, 2001; Sheng et al., 2001a, b) . Therefore, depending on ligand concentration and cellular background, the PI3K/Akt and Raf/Mek/Erk pathways synergize or work antagonistically (Jun et al., 1999; Moelling et al., 2002) . Synergy or antagonism between these two pathways leads to sustained or transient activation of signaling events, thereby influencing biological outcome.
Regulation of transcription factors by signaling pathways is a common theme. The transcriptional activity of Elk-1 is regulated by phosphorylation by MAPKs, including Erk (Sharrocks et al., 2000; ). The transcriptional activity of Elk-1 is also tightly regulated by protein-protein interactions. The interaction of Elk-1 with the coactivators CBP and/or Sur2 positively impacts Elk-1-mediated transcription events (Janknecht and Nordheim, 1996; Boyer et al., 1999; Nissen et al., 2001; Stevens et al., 2002) . On the other hand, the association of Elk-1 with ID-1 and the histone deacetylase mSin3A negatively regulates Elk-1 transcriptional activity Roberts et al., 2001; Yang et al., 2001) . In this report, we demonstrate that Akt regulates the transcriptional output from the Raf/Mek/Erk pathway by a novel mechanism, negatively regulating the translation of Elk-1. Neither the stability of the Elk-1 protein nor its message is regulated by Akt. Two experimental approaches point to translational control as being the mode of regulation. First, the rate of incorporation of [
35 S]methionine into Elk-1 protein is decreased when cells express activated Akt. Since the half-life of the Elk-1 protein and the steady-state levels of the Elk-1 message do not change in the presence of activated Akt, changes in the rate of incorporation of label are consistent with an effect on translation. Second, when Elk-1 and GFP are expressed from a bicistronic message, in which GFP is expressed from an internal IRES element, activated Akt decreases expression of Elk-1 but not GFP. Endonucleolytic cleavage of the Elk-1 message, without subsequent degradation, is one possible alternative to explain the uncoupling of protein synthesis from the bicistronic message. However, we do not see any evidence for endonucleolytic cleavage of the Elk-1 message in the presence of activated Akt by Northern analysis. Taken together, our results are consistent with regulated translational control of the Elk-1 message.
Our results support a role for Akt as a negative regulator of translation of Elk-1 and Sap1a. Yet other studies have demonstrated that Akt regulates the activities of ribosomal S6 kinase (S6 K) and 4E-BP1, by phosphorylating and negatively regulating the mTOR inhibitors TSC1 and TSC2 (Inoki et al., 2002; Manning et al., 2002; McManus and Alessi, 2002; Tee et al., 2002) . Activation of S6K and 4E-BP1 leads to increased translation of messages with highly structured 5 0 untranslated regions and increased cap-dependent translation (Gingras et al., 2001) . Rapamycin, an inhibitor of the TORs, does not affect Akt-mediated regulation of Elk-1 (data not shown), excluding a role for the well-characterized mTOR regulatory pathway in Elk-1 translational control by Akt. Whether Akt positively or negatively impacts translation may depend on the strength and/or duration of the signal from Akt. In our experiments, Akt signaling is sustained. In addition, Akt may both positively and negatively regulate subsets of translational events with this dual regulation influencing biological outcome.
Decreased translation of the Elk-1 message by Akt is not due to an inability of the Elk-1 message to access the ribosomes, since expression of GFP from an IRES element in a bicistronic message with Elk-1 is unaffected by activated Akt. The decrease in Elk-1 protein in the presence of activated Akt maps to a determinant located within the first 279 nts of the Elk-1 message. Internal translational control elements, while rare, have been reported. c-Myc contains a coding region determinant that induces translational pausing. The translational pause sites map to a rare CGA arginine codon and an adjacent ACA threonine codon. In the case of c-Myc, pausing is coupled to rapid degradation of the c-Myc message (Lemm et al., 2002) .
Rare codons (www.kazusa.or.jp/codon) (Nakamura et al., 2000) are present within the first 279 nts of the Elk-1 and Sap1a messages. A rare leucine CUA codon (6.9 per 10 3 codons) and an adjacent arginine CGC codon (10.9 per 10 3 codons) are present in human Elk-1 (aa 48 and 49). A rare arginine CGU codon (4.7 per 10 3 codons) and an adjacent leucine CUC codon (19.4 per 10 3 codons) are present in human Sap1a (aa 43 and 44). These codons are similar in frequency and in spacing to those present in the coding region determinant in c-Myc that promotes translational pausing (Lemm et al., 2002) . Therefore, pausing at rare codons could explain the low translation efficiency of the Elk-1 message in the presence of activated Akt.
Alternatively, translation of the Elk-1 message may be negatively regulated by an RNA-binding protein responding to activated Akt. There are numerous examples of RNA-binding proteins regulating translation, albeit most, but not all, act through regulatory elements in 5 0 and 3 0 untranslated regions (Macdonald, 2001; Dreyfuss et al., 2002; Timchenko et al., 2002) , which our constructs do not contain. Akt could act directly or by regulating a downstream kinase. Future experiments will be directed at testing these models.
We have demonstrated here that activated Akt regulates translation of the Elk-1 message. This regulation of Elk-1 expression by Akt may be one additional mechanism by which Akt promotes cell survival. c-fos expression promotes cell death in a number of different systems, including rod photoreceptor cells, mouse mammary epithelial cells, and Fos-lacZ transgenic mice (Smeyne et al., 1993; Marti et al., 1994; Preston et al., 1996 Preston et al., , 2000 Rich et al., 1997) . Akt may promote cell survival, in part, by decreasing transcriptional output from c-fos by negatively regulating Elk-1 protein levels.
Regulation of Elk-1 by Akt, and consequently c-fos, may also play a role in facilitating myogenesis. During muscle cell differentiation, c-fos expression declines and activated c-fos prevents myogenesis (Lassar et al., 1989; Trouche et al., 1993) . These results suggest that negative regulation of c-fos may facilitate muscle cell differentiation. Akt is upregulated as muscle cells differentiate (Kaneko et al., 2002) , so it is appropriately poised to regulate this transition. Future experiments will be directed at exploring the impact of Akt-mediated negative regulation of Elk-1, and c-fos, during these cell state transitions.
Materials and methods
Plasmids
CS2 þ myr-Akt expresses a constitutively active, membranelocalized full-length mouse Akt1 (Kohn et al., 1998) . CS2 þ myr-Akt K/D expresses a constitutively membraneNegative regulation of Elk-1 translation by Akt C Figueroa and AB Vojtek localized, carboxyl terminally truncated Akt1 (aa 1-647), which is catalytically inactive (Andjelkovic et al., 1997) . CS2 þ GST-Elk-1 expresses full-length Elk-1 fused at its amino terminus to GST. CS2 þ Gal-ElkFL expresses full-length Elk-1 fused at its amino terminus to the Gal4 DNA-binding domain, aa 1-147. CS2 þ Gal-ELkEts þ B, CS2 þ Gal-ElkCT, and CS2 þ Gal-ElkNT express aa 1-206, 205-428, and 1-93 of Elk-1, respectively, fused at the amino terminus to the Gal4 DNA-binding domain. All CS2 þ Elk expression vectors (fulllength and deletion constructs) were constructed by PCR amplification of the Elk-1 cDNA (from pcDNA3-HA-Elk-1) with Expand (Roche) and Elk-1-specific oligonucleotides primers. CS2 þ Elk expression vectors contain only Elk-1 coding region sequences; these vectors do not contain 5 0 or 3 0 Elk-1-derived untranslated regions. CS2 þ MT-CAP expresses full-length CAP fused at its amino terminus to six copies of the Myc epitope tag (Vojtek and Cooper, 1993) . CS2 þ GSTSap1a was made by PCR amplification of Sap1a (full length, coding region sequences only) from a human Sap1a cDNA. CS2 þ , CS2 þ luciferase, CS2 þ G4DBD (which expresses aa 1-147 of the Gal4 DNA-binding domain), and CS2 þ IRESeGFP were generous gifts of Dr David L Turner (University of Michigan). The simian CMV promoter drives expression of the fusion proteins in the CS2 þ vectors (Turner and Weintraub, 1994) . The c-fos-luciferase reporter (Yamauchi et al., 1993) , RSV-HA-C/A SGK (S422D), pCMV5-C/A Mek1 (Mansour et al., 1994) , and pCMV-b-galactosidase were obtained from Dr Kun-Liang Guan (University of Michigan). All constructs were sequence verified. 
Western blot analysis
HEK 293 cells were lysed 18-20 h after transfection with immunoprecipitation (IP) buffer (10 mm HEPES, pH 7.4, 50 mm NaF, 50 mm NaCl, 1% Triton X-100, 2 mm EDTA, 0.1% b-mercaptoethanol, 1% aprotinin, 1 mm PMSF). Total protein concentration was determined using a Bradford dyebinding procedure (Bio-Rad). Normalized proteins were resolved by SDS-PAGE. Antibodies: a-Elk-1 (CST), aAkt-1 (CST), a-phospho-Elk-1 (CST), a-phospho-Akt (S473) (CST), aHA (Babco), a-G4DBD (Clontech), aGST (provided by Jonathan A Cooper), and a-Myc antibody (9E10) (harvested from hybridoma cells).
Metabolic labeling, pulse, and pulse-chase
In vivo metabolic labeling and pulse-chase experiments were performed as described (Steinhilb et al., 2001) . After pulse or pulse-chase with 100 mCi [ 35 S]methionine (75 mCi/ml) (Amersham), the cells were lysed in IP buffer. GST-Elk-1 was captured on glutathione-sepharose beads and MT-CAP was immunoprecipitated with a-Myc antibody. The proteins in the pull-downs and immunoprecipitates were resolved by SDS-PAGE. GST-Elk-1, MT-CAP, and total proteins from cell extracts were detected by autoradiography and phosphorimage analysis using IPLabGel software (Signal Analysis Corporation). Data was graphed using Kaleidagraph or Excel. GST-Elk-1 and MT-CAP were detected by Western blot analysis (a-Elk-1 and a-Myc). The pulse-chase was performed three times; the pulse was performed four times. A representative experiment is shown in Figures 3 and 5 .
Northern blot analysis
RNA from transfected 293 cells was isolated using Trizol reagent (Invitrogen). In all, 5 mg of RNA samples were subjected to Northern blot analysis essentially as described (Vojtek and Cooper, 1993) .
32 P-labeled antisense probes for nts 366-680 of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the GAL4 DNA-binding domain were prepared by PCR (Vojtek and Cooper, 1993) . The membranes were hybridized with B2 Â 10 6 counts/min for GAPDH and B1 Â 10 6 counts/min for the G4DBD. The blots were exposed to X-ray film and/or to a phosphorimager screen for quantification of the data using the IPLabGel software.
Luciferase assays
Cos-1 cells were transiently transfected with expression vectors for a c-fos promoter-controlled luciferase reporter (Yamauchi et al., 1993) , C/A Mek1, pcDNA3-b-galactosidase, Myr-Akt (active or kinase inactive), and pcDNA3 to keep total DNA equal to 1 mg. Luciferase and b-galactosidase activity were measured 36-40 h after transfection using the Tropix Dual-Light reporter gene assay system (Applied Biosystems) in a Berthold Lumat LB9507 luminometer. Luciferase readings were normalized with respect to bgalactosidase. Assays were done at least twice in duplicate and/or quadruplicate.
